Literature DB >> 28268100

Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.

Emilia M Gatto1, Ricardo F Allegri2, Gustavo Da Prat3, Patricio Chrem Mendez4, David S Hanna5, Michael O Dorschner5, Ezequiel I Surace6, Cyrus P Zabetian7, Ignacio F Mata8.   

Abstract

Frontotemporal lobar degeneration is a neuropathological disorder that causes a variety of clinical syndromes including frontotemporal dementia (FTD), progressive supranuclear palsy, and corticobasal syndrome (CBS). FTD associated with parkinsonism occurs frequently as a result of mutations in the C9orf72 gene and also in the genes coding for the protein associated with microtubule tau (MAPT) and progranulin (GRN) on chromosome 17 (FTDP-17). Herein, we report an Argentinean family, of Basque ancestry, with an extensive family history of behavioral variant of FTD. Twenty-one members over 6 generations composed the pedigree. An extensive neurologic and neurocognitive examination was performed on 2 symptomatic individuals and 3 nonsymptomatic individuals. Two different phenotypes were identified among affected members, CBS in the proband and FTD in his brother. DNA was extracted from blood for these 5 individuals and whole-exome sequencing was performed on 3 of them followed by Sanger sequencing of candidate genes on the other 2. In both affected individuals, a missense mutation (p.P301L; rs63751273) in exon 10 of the MAPT gene (chr17q21.3) was identified. Among MAPT mutations, p.P301L is the most frequently associated to different phenotypes: (1) aggressive, symmetrical, and early-onset Parkinsonism; (2) late parkinsonism associated with FTD; and (3) progressive supranuclear palsy but only exceptionally it is reported associated to CBS. This is the first report of the occurrence of the p.P301L-MAPT mutation in South America and supports the marked phenotypic heterogeneity among members of the same family as previously reported. Published by Elsevier Inc.

Entities:  

Keywords:  CBS; Cognition; FTD; MAPT; P301L

Mesh:

Substances:

Year:  2017        PMID: 28268100      PMCID: PMC5385275          DOI: 10.1016/j.neurobiolaging.2017.02.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  34 in total

1.  A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy.

Authors:  Andrew Grover; Elisabet England; Mathew Baker; Naruhiko Sahara; Jennifer Adamson; Brian Granger; Henry Houlden; Ulla Passant; Shu-Hui Yen; Michael DeTure; Michael Hutton
Journal:  Exp Neurol       Date:  2003-11       Impact factor: 5.330

Review 2.  Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic.

Authors:  Shan-Shan Tang; Jun Li; Lan Tan; Jin-Tai Yu
Journal:  J Alzheimers Dis       Date:  2016-04-19       Impact factor: 4.472

Review 3.  Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies.

Authors:  Ian R A Mackenzie; Manuela Neumann
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

4.  Pick-body-like inclusions in corticobasal degeneration differ from Pick bodies in Pick's disease.

Authors:  Kenji Ikeda; Haruhiko Akiyama; Tetsuaki Arai; Kuniaki Tsuchiya
Journal:  Acta Neuropathol       Date:  2001-10-31       Impact factor: 17.088

5.  Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease.

Authors:  Claude M Wischik; Roger T Staff; Damon J Wischik; Peter Bentham; Alison D Murray; John M D Storey; Karin A Kook; Charles R Harrington
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  The frontotemporal dementias in a tertiary referral center: classification and demographic characteristics in a series of 232 cases.

Authors:  Panagiotis Ioannidis; Elina Konstantinopoulou; Pantelis Maiovis; Dimitris Karacostas
Journal:  J Neurol Sci       Date:  2012-04-26       Impact factor: 3.181

7.  Familial aggregation of parkinsonism in progressive supranuclear palsy.

Authors:  L Donker Kaat; A J W Boon; A Azmani; W Kamphorst; M M B Breteler; B Anar; P Heutink; J C van Swieten
Journal:  Neurology       Date:  2009-05-20       Impact factor: 9.910

8.  Deep clinical and neuropathological phenotyping of Pick disease.

Authors:  David J Irwin; Johannes Brettschneider; Corey T McMillan; Felicia Cooper; Christopher Olm; Steven E Arnold; Vivianna M Van Deerlin; William W Seeley; Bruce L Miller; Edward B Lee; Virginia M-Y Lee; Murray Grossman; John Q Trojanowski
Journal:  Ann Neurol       Date:  2015-12-25       Impact factor: 10.422

Review 9.  The genetics and neuropathology of frontotemporal lobar degeneration.

Authors:  Anne Sieben; Tim Van Langenhove; Sebastiaan Engelborghs; Jean-Jacques Martin; Paul Boon; Patrick Cras; Peter-Paul De Deyn; Patrick Santens; Christine Van Broeckhoven; Marc Cruts
Journal:  Acta Neuropathol       Date:  2012-08-14       Impact factor: 17.088

10.  Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations.

Authors:  Mariangela Iovino; Sylvia Agathou; Ana González-Rueda; Martin Del Castillo Velasco-Herrera; Barbara Borroni; Antonella Alberici; Timothy Lynch; Sean O'Dowd; Imbisaat Geti; Daniel Gaffney; Ludovic Vallier; Ole Paulsen; Ragnhildur Thóra Káradóttir; Maria Grazia Spillantini
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

View more
  4 in total

Review 1.  Unravelling Genetic Factors Underlying Corticobasal Syndrome: A Systematic Review.

Authors:  Federica Arienti; Giulia Lazzeri; Maria Vizziello; Edoardo Monfrini; Nereo Bresolin; Maria Cristina Saetti; Marina Picillo; Giulia Franco; Alessio Di Fonzo
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

Review 2.  Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities.

Authors:  Iñigo Ruiz-Barrio; Andrea Horta-Barba; Ignacio Illán-Gala; Jaime Kulisevsky; Javier Pagonabarraga
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.086

Review 3.  Neuropathology and emerging biomarkers in corticobasal syndrome.

Authors:  Shunsuke Koga; Keith A Josephs; Ikuko Aiba; Mari Yoshida; Dennis W Dickson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-06-13       Impact factor: 13.654

4.  Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries.

Authors:  Claudia Duran-Aniotz; Paulina Orellana; Tomas Leon Rodriguez; Fernando Henriquez; Victoria Cabello; María F Aguirre-Pinto; Tamara Escobedo; Leonel T Takada; Stefanie D Pina-Escudero; Oscar Lopez; Jennifer S Yokoyama; Agustin Ibanez; Mario A Parra; Andrea Slachevsky
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.